NOVA-BCL6-1 Trademark

Trademark Overview

On Friday, October 24, 2025, a trademark application was filed for NOVA-BCL6-1 with the United States Patent and Trademark Office. The USPTO has given the NOVA-BCL6-1 trademark a serial number of 99461075. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Friday, October 24, 2025. This trademark is owned by Eli Lilly and Company. The NOVA-BCL6-1 trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical and scientific research in the field of blood diseases and disorders and cancer
nova-bcl6-1

General Information

Serial Number99461075
Word MarkNOVA-BCL6-1
Filing DateFriday, October 24, 2025
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateFriday, October 24, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesMedical and scientific research in the field of blood diseases and disorders and cancer

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, October 24, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameEli Lilly and Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Trademark Events

Event DateEvent Description
Friday, October 24, 2025NEW APPLICATION ENTERED
Friday, October 24, 2025APPLICATION FILING RECEIPT MAILED

Related Keywords

nova diseases disorders cancer blood field scientific research medical